Benjamin J. Hindson - 22 Feb 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: President and Chief Scientific Officer, Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Issuer symbol: TXG
Transactions as of: 22 Feb 2023
Net transactions value: -$83,186
Form type: 4
Filing time: 24 Feb 2023, 16:51:51 UTC
Previous filing: 16 Dec 2022
Next filing: 23 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Sale	$83,186	-1,742	-0.69%	$47.75	250,237	22 Feb 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

President and Chief Scientific Officer